CIK 0001761612 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in X0 · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 72.6 M | 14.5 M | ||
| Net income (USD) | -112.7 M | -66.8 M | -51.0 M | |
| Diluted EPS (USD/shares) | -3.16 | -3.8 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-07 | 4/A | 4/A | 2026-10-02 |
| 2026-10-06 | 4 | 4 | 2026-10-02 |
| 2026-10-06 | 4 | 4 | 2026-10-02 |
| 2026-10-06 | 4 | 4 | 2026-10-02 |
| 2026-10-06 | 4 | 4 | 2026-10-02 |
| 2026-10-06 | 4 | 4 | 2026-10-02 |
| 2026-10-06 | 4 | 4 | 2026-10-02 |
| 2026-10-06 | 3/A | 3/A | 2023-06-22 |
| 2026-10-02 | 144 | 144 | |
| 2026-08-20 | 8-K | FORM 8-K items 5.02 | 2026-08-18 |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-30 | 10-Q | 10-Q | 2026-06-30 |
| 2026-07-30 | 8-K | FORM 8-K items 2.02,9.01 | 2026-07-30 |
| 2026-07-17 | 4 | 4 | 2026-07-15 |
| 2026-07-17 | 4 | 4 | 2026-07-15 |
| 2026-07-17 | 4 | 4 | 2026-07-15 |
| 2026-07-17 | 4 | 4 | 2026-07-15 |
| 2026-07-07 | 4 | 4 | 2026-07-02 |
| 2026-07-07 | 4 | 4 | 2026-07-02 |
| 2026-07-07 | 4 | 4 | 2026-07-02 |
| 2026-07-07 | 4 | 4 | 2026-07-02 |
| 2026-07-07 | 4 | 4 | 2026-07-02 |
| 2026-07-02 | 144 | 144 | |
| 2026-06-18 | 8-K | FORM 8-K items 5.07 | 2026-06-17 |
| 2026-05-21 | 8-K | FORM 8-K items 8.01,9.01 | 2026-05-21 |
Forms on file (last 1,000): 4 253, 8-K 93, 144 85, 3 38, 10-Q 22, SC 13G/A 21, SCHEDULE 13G/A 13, SC 13D/A 12. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=BCYC (0.002 USD), /gw/filings/filings?ticker=BCYC&form=8-K, /gw/filings/facts?ticker=BCYC&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange